154 related articles for article (PubMed ID: 7665638)
1. Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group.
Henrard DR; Soriano V; Robertson E; Gutierrez M; Stephens J; Dronda F; Miles F; Pujol E; Buytendorp M; Castro A
J Clin Microbiol; 1995 Jul; 33(7):1735-8. PubMed ID: 7665638
[TBL] [Abstract][Full Text] [Related]
2. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
3. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) in selected Tijuana subpopulations.
Guerena-Burgueno F; Benenson AS; Sepulveda-Amor J; Ascher MS; Vugia DJ; Gallo D
Am J Trop Med Hyg; 1992 Aug; 47(2):127-32. PubMed ID: 1503181
[TBL] [Abstract][Full Text] [Related]
5. HTLV infection among Italian intravenous drug users and North African subjects detected by the polymerase chain reaction and serological methods.
Colombo E; Magistrelli C; Mendozzi E; Cattaneo E; Achilli G; Ferrante P
J Med Virol; 1995 Sep; 47(1):10-5. PubMed ID: 8551251
[TBL] [Abstract][Full Text] [Related]
6. Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil.
Jacob F; Santos-Fortuna Ede L; Azevedo RS; Caterino-de-Araujo A
Rev Inst Med Trop Sao Paulo; 2007; 49(6):361-4. PubMed ID: 18157402
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of human T-cell lymphotropic virus type I/II in northeastern Brazil.
Moreira ED; Ribeiro TT; Swanson P; Sampaio Filho C; Melo A; Brites C; Badaró R; Toedter G; Lee H; Harrington W
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):959-63. PubMed ID: 8315579
[TBL] [Abstract][Full Text] [Related]
8. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
Feigal E; Murphy E; Vranizan K; Bacchetti P; Chaisson R; Drummond JE; Blattner W; McGrath M; Greenspan J; Moss A
J Infect Dis; 1991 Jul; 164(1):36-42. PubMed ID: 2056217
[TBL] [Abstract][Full Text] [Related]
9. Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).
Campos KR; Gonçalves MG; Costa NA; Caterino-de-Araujo A
Braz J Infect Dis; 2017; 21(3):297-305. PubMed ID: 28343818
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
van den Hoek JA; Al EJ; Huisman JG; Goudsmit J; Coutinho RA
J Med Virol; 1991 Jun; 34(2):100-3. PubMed ID: 1890409
[TBL] [Abstract][Full Text] [Related]
11. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
12. HTLV-I and -II in intravenous drug users from Sweden and Denmark.
Blomberg J; Moestrup T; Frimand J; Hansson BG; Krogsgaard K; Grillner L; Nordenfelt E
Scand J Infect Dis; 1994; 26(1):23-6. PubMed ID: 8191236
[TBL] [Abstract][Full Text] [Related]
13. [Multicenter study of HTLV-I and HTLV-II infection in Spain. Spanish Group for the Study of HTLV-II/II Infection].
Soriano V; Calderón E; Cilla G; Aguilera A; Merino F; Gutiérrez M
Med Clin (Barc); 1993 Apr; 100(13):492-6. PubMed ID: 8479231
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.
Catalan-Soares B; Carneiro-Proietti AB; Proietti FA;
Cad Saude Publica; 2005; 21(3):926-31. PubMed ID: 15868051
[TBL] [Abstract][Full Text] [Related]
15. HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group.
Soriano V; Calderón E; Esparza B; Cilla G; Aguilera A; Gutiérrez M; Tor J; Pujol E; Merino F; Pérez-Trallero E
Int J Epidemiol; 1993 Aug; 22(4):716-9. PubMed ID: 8225748
[TBL] [Abstract][Full Text] [Related]
16. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.
Treviño A; Aguilera A; Caballero E; Benito R; Parra P; Eiros JM; Hernandez A; Calderón E; Rodríguez M; Torres A; García J; Ramos JM; Roc L; Marcaida G; Rodríguez C; Trigo M; Gomez C; de Lejarazu RO; de Mendoza C; Soriano V;
Virol J; 2012 Mar; 9():71. PubMed ID: 22444832
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HTLV types I and II among drug users in King County, Washington.
Thiede H; Harris NV; McGough JP; Roberts B; Khabbaz RF; Kaplan JE
West J Med; 1994 Jun; 160(6):540-4. PubMed ID: 8053176
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.
Olaleye OD; Ekweozor CC; Li ZL; Opala IE; Sheng Z; Onyemenem TN; Rasheed S
Arch Virol; 1996; 141(2):345-55. PubMed ID: 8634025
[TBL] [Abstract][Full Text] [Related]
19. HTLV infections among Swedish intravenous drug users in 1992.
Andersson S; Krook A; Käll K; Julander I; Thorstensson R; Biberfeld G
Scand J Infect Dis; 1995; 27(6):547-50. PubMed ID: 8685631
[TBL] [Abstract][Full Text] [Related]
20. Estimation of the window period of human T-cell leukemia virus type 1 and 2 tests by a lookback study of seroconverters among Japanese voluntary blood donors.
Sagara Y; Nakamura H; Yamamoto M; Ezaki T; Koga T; Shimamura M; Satake M; Irita K
Transfusion; 2021 Feb; 61(2):484-493. PubMed ID: 33368334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
